Related Experiment Videos
IRS proteins and the common path to diabetes
1Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA. morris.white@joslin.harvard.edu
American Journal of Physiology. Endocrinology and Metabolism
|August 10, 2002
Summary
Insulin receptor substrate (IRS) proteins, especially IRS-2, are crucial for insulin signaling, beta-cell function, and nutrient sensing. Their dysregulation contributes to insulin resistance and beta-cell failure.
Area of Science:
- Cellular signaling
- Endocrinology
- Molecular biology
Background:
- Insulin/Insulin-like Growth Factor (IGF) signaling is vital for numerous cellular processes.
- Insulin receptor substrate (IRS) proteins link cell surface receptors to intracellular cascades, adding specificity.
- IRS-2 is particularly important for peripheral insulin response and pancreatic beta-cell function.
Purpose of the Study:
- To elucidate the role of IRS proteins in insulin/IGF signaling.
- To understand the contribution of IRS-2 to pancreatic beta-cell function and insulin resistance.
- To explore the regulatory mechanisms of IRS protein function.
Main Methods:
- The study discusses the known functions and signaling pathways involving IRS proteins.
- It examines the consequences of IRS protein inhibition and degradation.
- The research integrates findings on IRS-1 and IRS-2 in various physiological contexts.
Main Results:
- IRS proteins provide specificity to Insulin/IGF receptor signaling.
- IRS-2 signaling is critical for pancreatic beta-cell growth and function.
- Inhibition of IRS proteins via phosphorylation or degradation is linked to insulin resistance and beta-cell destruction.
Conclusions:
- IRS proteins are central regulators of insulin/IGF action, impacting nutrient sensing, development, and aging.
- Dysfunctional IRS-2 signaling contributes to the loss of compensatory hyperinsulinemia in insulin resistance.
- Mechanisms of IRS protein inhibition highlight common pathways in insulin resistance and autoimmune beta-cell destruction.